Swedish Orphan Biovitrum AB

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000872095
SEK
444.00
8.8 (2.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
7,184.00
7,821.00
7,776.00
6,175.00
6,465.00
7,436.00
6,894.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,184.00
7,821.00
7,776.00
6,175.00
6,465.00
7,436.00
6,894.00
Raw Material Cost
2,428.00
2,231.00
9,040.00
2,247.00
2,400.00
2,525.00
2,175.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
173.00
185.00
168.00
216.00
262.00
225.00
326.00
Selling and Distribution Expenses
1,821.00
2,214.00
-4,850.00
1,882.00
1,776.00
2,280.00
1,809.00
Other Expenses
75.50
69.40
58.60
56.70
57.20
75.60
51.90
Total Expenditure (Excl Depreciation)
5,177.00
5,324.00
4,944.00
4,912.00
5,010.00
5,786.00
4,829.00
Operating Profit (PBDIT) excl Other Income
2007
2497
2832
1263
1455
1650
2065
Other Income
0.00
4.00
-26.00
-16.00
-6.00
-4.00
15.00
Operating Profit (PBDIT)
2,789.00
3,255.00
10,321.00
2,136.00
2,387.00
2,578.00
3,004.00
Interest
173.00
185.00
168.00
216.00
262.00
225.00
326.00
Exceptional Items
-139.00
-142.00
-6,664.00
-237.00
-92.00
15.00
-41.00
Gross Profit (PBDT)
4,756.00
5,590.00
-1,264.00
3,928.00
4,065.00
4,911.00
4,719.00
Depreciation
782.00
754.00
7,515.00
889.00
938.00
932.00
924.00
Profit Before Tax
1,695.00
2,174.00
-4,027.00
794.00
1,096.00
1,437.00
1,712.00
Tax
363.00
309.00
-1,132.00
160.00
221.00
47.00
248.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,318.00
1,862.00
-2,895.00
636.00
875.00
1,397.00
1,464.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,318.00
1,862.00
-2,895.00
636.00
875.00
1,397.00
1,464.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
-2.00
0.00
-6.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,318.00
1,862.00
-2,895.00
634.00
875.00
1,391.00
1,464.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.55
0.55
0.55
0.55
0.55
0.55
0.55
Reserves
40,377.00
37,717.00
35,976.00
39,061.00
39,029.00
40,286.00
37,094.00
Earnings per share (EPS)
3.77
5.34
-8.4
1.83
2.52
4.03
4.22
Diluted Earnings per share
3.77
5.34
-8.4
1.83
2.52
4.03
4.22
Operating Profit Margin (Excl OI)
27.94%
31.93%
36.42%
20.45%
22.51%
22.19%
29.95%
Gross Profit Margin
34.48%
37.44%
44.86%
27.26%
31.46%
31.86%
38.24%
PAT Margin
18.35%
23.81%
-37.23%
10.3%
13.53%
18.79%
21.24%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 11.12% vs 3.34% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 50.63% vs 9.38% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 16.55% vs 0.29% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -33.97% vs -20.85% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Swedish Orphan Biovitrum AB With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
7,184.00
184.04
6,999.96
3,803.50%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,184.00
184.04
6,999.96
3,803.50%
Raw Material Cost
2,428.00
15.06
2,412.94
16,022.18%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
173.00
4.93
168.07
3,409.13%
Selling and Distribution Expenses
1,821.00
49.45
1,771.55
3,582.51%
Other Expenses
75.50
7.99
67.51
844.93%
Total Expenditure (Excl Depreciation)
5,177.00
149.36
5,027.64
3,366.12%
Operating Profit (PBDIT) excl Other Income
2,007.00
34.68
1,972.32
5,687.20%
Other Income
0.00
9.33
-9.33
-100.00%
Operating Profit (PBDIT)
2,789.00
47.16
2,741.84
5,813.91%
Interest
173.00
4.93
168.07
3,409.13%
Exceptional Items
-139.00
0.00
-139.00
Gross Profit (PBDT)
4,756.00
168.97
4,587.03
2,714.70%
Depreciation
782.00
3.15
778.85
24,725.40%
Profit Before Tax
1,695.00
39.07
1,655.93
4,238.37%
Tax
363.00
47.90
315.10
657.83%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,318.00
-8.83
1,326.83
15,026.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,318.00
-8.83
1,326.83
15,026.39%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,318.00
-8.83
1,326.83
15,026.39%
Equity Capital
0
0
0.00
Face Value
0.55
0.02
0.00
Reserves
40,377.00
1,967.08
38,409.92
1,952.64%
Earnings per share (EPS)
3.77
-0.10
3.87
3,870.00%
Diluted Earnings per share
3.77
-0.10
3.87
3,870.00%
Operating Profit Margin (Excl OI)
27.94%
18.84%
0.00
9.10%
Gross Profit Margin
34.48%
22.94%
0.00
11.54%
PAT Margin
18.35%
-4.80%
0.00
23.15%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 718.40 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.14% vs 0.58% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 11.12% vs 3.34% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 131.80 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -29.22% vs 164.32% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 50.63% vs 9.38% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 278.90 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -14.21% vs -68.58% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 16.55% vs 0.29% in Mar 2025

Quarterly - Interest
Interest 17.30 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.49% vs 10.12% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -33.97% vs -20.85% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.94%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025